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ABSTRACT The inbred BALB/c mouse has three trans-
plantation antigens, H2-Kd, H2-Ld, and H2-Dd. We present
the complete nucleotide sequence of the H2-Dd gene as well as
777 residues of previously unpublished H-2Dd protein se-
quence. These data complete the sequences of all the BALB/c
transplantation antigen genes and permit detailed comparison
with each other and with their counterparts from the inbred
C57BL/10 mouse. Transplantation antigens may differ from
one another by as much as 5%-15% of their amino acid
sequence for the external domains. These extensive differences
may arise by gene conversion. The H-2D region of the BALB/c
mouse encodes the H2-Dd and the H2_Ld genes. Serologic data
suggest that at least two additional transplantation antigen
molecules, H2-Rd and H2_Md, are encoded in the H-2D region
of the major compatibility complex. Paradoxically, gene clon-
ing studies have only identified the H2-Dd and the H2-Ld genes
in the H-2D region. A complete DNA sequence of the H2-Dd
gene shows that a variety of alternative splice sites exist
throughout the gene, which may lead to additional gene
products and may explain the multiplicity of H-2D-encoded
polypeptides.
The major histocompatibility complex (MHC) of the mouse,
located on chromosome 17, has four regions that contain
class I genes: H-2D, H-2K, Qa, and the Tla complex (1-4).
Class I molecules are heterodimers consisting of a 45,000-Da
integral membrane glycoprotein noncovalently associated
with 82-microglobulin, a 12,000-Da polypeptide encoded by
a gene on chromosome 2. These molecules can be divided
into two categories based on differences in their expression,
the extent of their serologically detectable polymorphism,
and their functions. The class I heavy chains encoded by the
Tla complex are differentiation antigens of unknown func-
tion that are expressed on the surfaces of certain
hematopoietic cells and are only moderately polymorphic.
The transplantation antigens, encoded by genes in the H-2D
and H-2K regions, are among the most polymorphic mol-
ecules known, as >50 different alleles have been described
for each of the H-2D and H-2K loci so far (3). Different
strains of mice possess different sets of alleles at MHC loci.
These constellations of alleles are known as haplotypes.
Transplantation antigens are found on the surfaces of virtu-
ally all somatic cells. Cytotoxic T cells recognize cell-surface
viral or tumor antigens only in the context of a self-
transplantation antigen, a phenomenon known as H-2 re-
striction (5). Transplantation antigens are, therefore, also
known as restriction elements.
Recently, a number of transplantation antigen genes from
several different haplotypes have been isolated and charac-
terized (refs. 6-13; unpublished observations). Two different
transplantation antigen genes, the H-2Kb and H-2Db genes,
have been isolated from C57BL/10 mice (H-2b haplotype),
and three transplantation antigen genes, the H-2Kd, H-2Ld,
and H-2Dd genes, have been isolated from BALB/c mice
(H-2d haplotype). The H-2K genes map to the H-2K region of
the MHC, while the H-2D and H-2L genes map to the H-2D
region (14). In BALB/c mice, there is serological evidence
that the H-2D region may encode other transplantation
antigens, including H-2Md and H-2Rd (15, 16). Genes encod-
ing these proteins have not yet been isolated.
The H-2D-region transplantation antigens H-2Dd, H-2Ld,
and H-2Db are particularly interesting because of their
structural interrelationships. Most transplantation antigens
are only 80%o-85% homologous to each other at the protein
sequence level (1-4). This is true for presumptive allelic gene
products such as H-2Kb and H-2Kd. This is also true in
comparisons between the 183 residues of partial H-2Dd
protein sequence and the translated coding sequences of the
H-2Db and H-2Ld genes (refs. 9, 17, 18; unpublished obser-
vations). Surprisingly, the protein sequences of H-2Ld and
H-2Db are 95% homologous to each other. This unprece-
dented level of homology has led to the suggestion that the
H-2Ld and H-2Db genes are allelic (13, 18) and that the
H-2Dd gene may be derived from a different locus. However,
only one H-2D subregion H-2b haplotype class I gene has
been cloned-namely, the H-2Db gene (8). Thus, the number
of class I genes in the H-2D subregion of different haplotypes
is variable, and the allelic relationships between the H-2D
subregion class I genes of different haplotypes are unclear.
To shed light on the relationship between H-2Dd and the
other H-2D-encoded transplantation antigens, it is necessary
to know the structure of the H-2Dd gene. We present
substantial previously unreported H-2Dd protein sequence
and the complete DNA sequence of the H-2Dd gene.
MATERIALS AND METHODS
Cosmid clone c49.2 was isolated from a BALB/c Cum sperm
DNA cosmid library as described (ref. 11; M. Steinmetz,
personal communication). The construction of M13mp8
subclones and dideoxy sequencing were as described (9, 19,
20). Protein sequencing was as described (21, 22).
RESULTS
The Class I Gene in Cosmid Clone c49.2 Encodes H-2Dd.
Gene 49.2, whose structure and sequence are shown in Figs.
1 and 2, has been shown to encode H-2Dd on the basis of
several criteria. Previously, it has been shown that mouse L
cells (H-2k haplotype) transfected with c49.2 express a
protein that reacts with the H-2Dd1specific monoclonal anti-
bodies 34-5-8 and 34-2-12 (R. S. Goodenow, personal com-
munication). Comparison of the translated coding sequence
of gene c49.2 with the available protein sequence also
supports the conclusion that this is an H-2Dd gene.
Abbreviation: MHC, major histocompatibility complex.
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FIG. 1. Structure of the H-2Dd gene and strategy used to determine its sequence. A battery of restriction enzymes (Hha I, Sau3A, Sau96A,
Rsa I, and Alu I) was used to generate shotgun mp8 subclones from the 2.2-kilobase (kb) BamHI fragment and the 4.2-kb Kpn I fragment
containing the 5' and 3' ends of the gene. These subclones were sequenced by the dideoxy method. The locations of B1 and B2 sequences are
indicated. Numbers given are distances in nucleotides.
The partial protein sequence of the H-2Dd molecule is
presented in Fig. 3. This sequence includes 77 previously
unpublished residues, 8 of which are still tentatively identi-
fied. In addition, 10 residues that had previously been
published as tentative are now confirmed. The translated
gene c49.2 sequence is in perfect agreement with all of the
available H-2Dd protein data (254 of 254 residues).
The intron/exon structure of the c49.2 H-2Dd gene pre-
sented in Figs. 1 and 2 was proposed on the basis of
comparison with the available H-2Dd protein sequence and
with the DNA sequences of two cDNAs, pH-21 (23) and
pH-2d_1 (24). Each cDNA is >99% homologous to the coding
sequence of the H-2Dd gene. Therefore, they were probably
derived from H-2d gene transcripts. The H-2Dd gene has the
same general exon/intron structure as the other murine class
I genes that have been characterized (refs. 6-13, 25; un-
published observations). The first exon encodes a hydro-
phobic signal peptide that is not present in the mature
protein. The second, third, and fourth exons encode the
three external domains of the H-2Dd protein-al, a2, and
a3. The third and fourth exons are separated by a large
intron. The fifth exon encodes the transmembrane segment
of the H-2Dd protein, and exons 6, 7, and 8 encode the
cytoplasmic portion of the molecule. The polyadenylylation
signal sequence A-A-T-A-A-A appears 463 nucleotides 3' to
the termination codon in exon 8 (26). Thus, as has been
observed for other transplantation antigen genes, the
intron/exon structure of the H-2Dd gene corresponds pre-
cisely with the domain structure of the H-2Dd protein.
The H-2Dd Gene Contains Potential Alternative Splicing
Met Gly Ala Met Ala Pro Arg Thr Leu Leu Leu Leu Leu Ala Ala Ala Leu Gly Pro Thr Gln Thr Arg Ala G
GGATCCCAG ATG GGG GCG ATG GCT CCG CGC ACG CTG CTC CTG CTG CTG GCG GCC GCC CTG GGT CCG ACT CAG ACC CGC GCT G GTGAGTGCGTGG
TCGGGAGCGAAACGGCCTCTGCGGGGAGGGGGCGGCACGGGGGAAGCCGGTCCCCGCGTCGCCCACCGGACCCTCCGCTCCTTCTCCACCCGAGCCCCGGCGCCCAGATCCCCTCCCGGC
ly Ser His Ser Leu Arg Tyr Phe Val Thr Ala Val Ser Arg Pro
CCTGCGCAGCCGCCCGGGGTCCCGGGAGGAGATCGGGGTCTCACCGCGCGCCGCCCCCAG GC TCA CAC TCG CTG AGG TAT TTC GTC ACC GCC GTG TCC CGG CCC
Gly Phe Gly Glu Pro Arg Tyr Met Glu Val Gly Tyr Val Asp Asn Thr Glu Phe Val Arg Phe Asp Ser Asp Ala Glu Asn Pro Arg Tyr
GGC TTC GGG GAG CCC CGG TAC ATG GAA GTC GGC TAC GTG GAC AAC ACG GAG TTC GTG CGC TTC GAC AGC GAC GCG GAG AAT CCG AGA TAT
Glu Pro Arg Ala Arg Trp Ile Glu Gln Glu Gly Pro Glu Tyr Trp Glu Arg Glu Thr Arg Arg Ala Lys Gly Asn Glu Gln Ser Phe Arg
GAG CCG CGG GCG CGG TGG ATA GAG CAG GAG GGG CCG GAG TAT TGG GAG CGG GAG ACA CGG AGA GCC AAG GGC AAT GAG CAG AGT TTC CGA
Val Asp Leu Arg Thr Ala Leu Arg Tyr Tyr Asn Gln Ser Ala Gly G
GTG GAC CTG AGG ACC GCG CTG CGC TAC TAC AAC CAG AGC GCG GGC G GTGAGTGACCCCGGGTCGGAGGTCACGACCCCTACACTTCCCGACACAGGGACGCTGA
CGTCCCGGGTCCCAAGTCCGAGATTCGGGAACAGAACGGACCCGGACCCGGAGGCGGTTTCCCTTTCAGTTTGGAGGAGGTCGCGGGCGGGCGGGGCCGGGGCGGGTGAGCGGGGCTGAC
ly Ser His Thr Leu Gln Trp Met Ala Gly Cys Asp Val Glu Ser Asp Gly Arg Leu Leu Arg Gly Tyr Trp Gln Phe Ala
CGGGGTCCCGCAG GC TCT CAC ACA CTC CAG TGG ATG GCT GGC TGT GAC GTG GAG TCG GAC GGG CGC CTC CTC CGC GGG TAC TGG CAG TTC GCC
Tyr Asp Gly Cys Asp Tyr Ile Ala Leu Asn Glu Asp Leu Lys Thr Trp Thr Ala Ala Asp Met Ala Ala Gln Ile Thr Arg Arg Lys Trp
TAC GAC GGC TGC GAT TAC ATC GCC CTG AAC GAA GAC CTG AAA ACG TGG ACG GCG GCG GAC ATG GCG GCG CAG ATC ACC CGA CGC AAG TGG
Glu Gln Ala Gly Ala Ala Glu Arg Asp Arg Ala Tyr Leu Glu Gly Glu Cys Val Glu Trp Leu Arg Arg Tyr Leu Lys Asn Gly Asn Ala
GAG CAG GCT GGT GCT GCA GAG AGA GAC CGG GCC TAC CTG GAG GGC GAG TGC GTG GAG TGG CTC CGC AGA TAC CTG AAG AAC GGG AAT GCT
Thr Leu Leu Arg Thr A
ACG CTG CTG CGC ACA G GTGCAGGGGCCGCGGGCAGCTCCTCCCTCTGCCCTCGGGCTGGGGCTCAGTCCTGGGGAAGAAGAAACCCTCAGCTGGGGTGATGCCCTAGTCTCAGA
GGGGAGAGAGTGTCCCTGGGCCTCCTGATCCCTCATCTCAGGGACTGCACTGACTCTCCCAGGGCTCAGCTTCTCCCTGGACAGTGCCCAGGCTGTCTCAGGAGGGAAGGAGACAATTTC
CCTGAGGTAACAACAGCTGCTCCCTTCAGTTCCCCTGCAGCCTCTGTCAGCCATGGCCTCTCCCAGGCTGGGTTCTCTGCCCACGCCCACTGTCTGTAGACACTGACTCCTGTCCTGCTG
AGTGTGTCAGCCCTTACACCTCAGGACCGGAAGTCGCCTTACCTGATAAGA GACGATCCCCTACACTAGGCTGGTTGCCCCAGCTTCTAGAATTTTCCAGAGAATACATTCTCCCA
GATCCCTCCCCCTCCCTGTCTGTGGGGTTTGCACCCCTTCGACAACCCAATTCTCTCTATTCCTACAGTGGTGAATGGTCACATGAGCC AGTACTCCGGAGGAATATAAATCGA
GAATTTTCCTTTTTCTTTTCTCTCTCTTTTTTTTTTCCGATTTTTTTTGAGACAGGGTTTCTCTGTATAGCCCTGGCTGTCCTGGAACTCACTTTGTAGCCCAGGTTGTCCTCAAATTCA
CATGCCTCTGCCTCCTGAGTGCTGGGATTATGCTGCCCAGCCTTTCTTTTTTCTTTACTTTTTTTTTTTTTTTTTTTGAGGCCTTATTTTGTTTCTAGTCAGTTTTTGTCTGCACTGGAG
TGATCCTGTTTCTCCATGCCCTTGTATTATCATTTGTATCAGTCTCCACAGGTGCCAGAGTTGACTGCTAACCTGGATAATTATGCAAGTTAAATCAGGGTTCTCATTAAAGAAGAGATT
CTTGTGAACTAAGACTGTTTCCTGTCAGAACTAAACATCCAGAAGCCCCCTGCTCTCCCTCTGCCCCACAAGTTACAGTGCCCACCCCCCCCAGTGAATCAGGACTTGGACTCTGAGAGA
CAGGGTCTTCTGCAATCCACGCCCTATAGTGAGAGGGAAGACCACACACCCTCTGAGCTCACTGTGTTCCAGTGAGTGCTGCACTAGGGTCCACAGCTCACTCC CCCTGTGTGAC
ATACCTGTACCTTGTCCTCCAGAGTC AGGGACAGGGAGTCATTTTCTCTGGCTACAGACTTTGTGATGGCTGTTCACTCGGACTGAC AGTTAACGTTGGTC AGCAAGATGACCACAGTGG
TTGAGTCTCAGTGGTGGGACCCTTCCAGTAGCATATGCCCCTAATTTTGATATGAACTCAAACACATATTAAATTACTTATTTTCCATTCCCTATTCCATTCTGTGACTATCTCTCTCAT
GCTATTGAACATCACATAAGGATGGCCATGTTCACCCACTGGCTCATGTGGATTCCCTCTTAGCTTCTTTGTCCCAAAAGAAAATGTGCAGTCCTGTGCTGAGGGGACCAGCTCTGCTTT
TGGTCACTAGTGCAATGACAGTTGAAGCGTCAAACAGACACAGAGTTCACTGTCATCATTGATTTAACTGAGTCTTGTGTAGATTTCAGTTTGTCTTGTTAATTGTGGAATTTCTTAAAT
sp Pro Pro Lys Ala His Val Thr His His Arg Arg Pro Glu Gly Asp Val Thr Leu Arg Cys Trp Ala Leu Gly Phe Tyr P
CTTCCACACAG AT CCC CCA AAG GCC CAT GTG ACC CAT CAC CGC AGA CCT GAA GGT GAT GTC ACC CTG AGG TGC TGG GCC CTG GGC TTC TAC C
ro Ala Asp Ile Thr Leu Thr Trp Gln Leu Asn Gly Glu Glu Leu Thr Gln Glu Met Glu Leu Val Glu Thr Arg Pro Ala Gly Asp Gly T
CT GCT GAC ATC ACC CTG ACC TGG CAG TTG AAT GGG GAG GAG CTG ACC CAG GAA ATG GAC CTT GCTG GAG ACC AG CCT CCA GGG GAT GGA A
hr Phe Gln Lys Trp Ala Ser Val Val Val Pro Leu Gly Lys Glu Gln Lys Tyr Thr Cys His Val Glu His Glu Gly Leu Pro Glu Pro L
CC TTC CAG AAG TGG GCA TCT GTG GTG GTC CCT CTTAG AAGGAGA AC AA C TACA TGCAA CGGTGAGATCTCCAGC CT CCTTCAG CCC C
eu Thr Leu Arg Trp Gly Lys Glu G
TC ACC CTG AGA TGG GGC AAG GAC T GCTGACCTGCGCTGGCGTCAGCAAAGCTGGCAGCCTTCTCCAGACCCTCCCCTGGTCAGGGCTGAGGGCTGGGGTCATGACCCT
lu Pro Pro Ser Ser Thr Lys Thr Asn Thr Val Asn Asn Ala Val Pro Val Val Leu Gly Ala Val V
CACCTTCATTTCCTCTACCTCTCCTTCCCAC AG CCT CCT TCA TCC ACC AAC ACT AAC ACA GTA ATC ATT CCT CTT CCC CTT GTC CTT GA CC CAGTG G
al Asn Leu Gly Ala Val Met Ala Phe Val Met Lys Arg Arg Arg Asn Thr G
TC ATC CTT CCA GCT CTC ATC TCT TTT CTC ATG ACACAGGGCGA AAC ACA GC CTATGAAACCCCATGATCTGAGTTCCTCTCCAGCCTCCTTTAGAAGTGTAC
ACTGCTCATTAATGGAAACACAGCCACACCCCACATTCTACTGCTTTCTAACTCTGTCTGCTGTCAGTTCTGCAAACTTCCAGTGTCAAGATGTTCCTTCAACTCTCACAGCTTTTCTT
ly Cly Lys Gly Gly Asp Tyr Ala Leu Ala Pro G
CTCACAC CT CCA AAA CCA CCG CAC TAT CCT CTC CCT CCA C CTTACTATCCCCACACGATTGTCCTACACACATTCGAGTCAACTTCAAGATCATCCGACCTCTGCCA
ly Ser Cln Ser
ATCCATGATAGCTCCTCCAGAGAAATCTTCTACTTCCCTGACTTCTCCCATCAAATGAATACATTCATGTACATATGCATACACATTTCTTTTCTTTTACCCTAC CC TCC CAC ACC
Ser Asp Met Ser Leu Pro Asp Cys Lys V
TCT GAT ATG TCT CTC CCA GAT TGT AAA C CTG ACACTCTAGGGTCTGATTTCCCACCGGCAATGTGGACATGATTGGGTTTCAGCGACTCCCAGAATCTCCTGTGAGTCA
(ffi) ~~~~alTrm
GTCCTGGGTTCTTCCAATCTTCACTTCACAG'TCATCCTTCATCACTCTCATTCTCTAC TG TCA ACACACCTGCCTAGTCTCCACTTCCTGACAGACAATCTCTTCACACATCTCCTC
TCACATCCACACACCTCAGTTCTCTTTAGTCAAGTGTCTCATCTTCCCTCTGACTCTCCCCCCTCAAACTCAACAACTCTCCACCCCACTCCACCCCTCCACACCACCACCCTATCCCTG
CACTCCCCTGTCTTCCCTTCCACACCCAACCTTGCTGCTCCACCCAAACATTGGTCCACATCTGCAGCCTGTCAGCTCCATGCTACCCTGACCTTCAACTCCTCACTTCCACACTCAGAA
TAATAATTTCAATGTCGCTCCCTCCACACATCCCTCACCCCTGACTGCTCTTCCAAACCTCCTGAGTTCAAATCCCACCAACCACATCCTCCCTCACAACCATCTCTAATCCGATCTAAC
ACCCTCTTCTGCAGTGTCTGAAGACACCTACACTCTACTTACATATAATAATAAATAACTCTTTAAAAAATTAATTTCAAACTCACCTTCATTCTTAACATCTTCACCT
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FIG. 2. Sequence of the H-2Dd gene. Protein translations of exons are given above the DNA sequence. Potential alternative splice sites are
indicated by arrows.
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EXON II
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___________+-
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EXON IV
DPPKAHVTHHRRPEGDVTLRCWALGFYPADITLTWQLNGEELTQEMELVETRPAGDGTFQKWASVVVPLGKEQKYTCHVEHEGLPEPLTLRWGKE
* +++++++ + +++ + + ++ +++*+ + + U-----------4-=---------=. ---++++ F+++*
.S.P.SK.E.0.N.. .NR.Y.
.S.P.SK.E D N D .NR.Y.
.S. Y.P.SQV.....DDA . N.H.K.
..S.SDK.1I0.DY.Y.0.
....... .P.SY.A.D.V.N.DVN.NRW
.T...PGS.P . 0. DQ .N.Y.
EXON V EXON VI EXON VII EXON VIII
EPPSSTKTNTVI IAVPVVLGAVVILGAVMAFVMK RRRNT
...P.DSYM..V.LG....MA.IeVo....*.
...P.DSYMN..VLG....MA.I .V....V.
KL.P. .VS.T..L AIVT. ..V . M....
..P. .VS.MATV. .1. AIVTV... .M
.PY.VS.MAT ....V.D......A.I.. V.. oN .IXll
..P. ..DSIMSH. .DLLWPSLKLWWYLX
GGKGGDYALAP GSQSSODSLPDCK
.........E...
.........E..o..R
..V N ..T...L..ToLG.
.T.............ToL.
.. . .C.P.. . .X.. . R... .G.
FIG. 3. Protein sequences of several class I molecules are compared. Line denoted "H-2Dd pro" gives partial H-2Dd protein sequences.
Sequence identity is indicated by a dot; sequence differences are indicated by the one-letter amino acid code. Symbols on H-2Dd pro line are
as follows: *, newly published, tentative identification; =, previously tentative, now identified; +, previously unpublished, now identified; !,,
previously published, still tentative; -, previously published.
Signals. Recently, an alternative intron/exon organization
affecting the second exon has been proposed for the H-2Kd
gene (27). In a cDNA clone apparently derived from a
processed H-2Kd transcript, an alternative splice acceptor
site in the first intron 50 nucleotides 5' to the usual acceptor
site is used. In addition, an extra intron is created by the
splicing out of a region inside exon 2 containing amino acids
6-38. In the H-2Dd gene sequence, there is no potential
alternative splice acceptor site in the position corresponding
to that of the alternative acceptor site in the first intron of the
H-2Kd gene. There is, however, a potential alternative splice
acceptor site in the first intron in frame 51 nucleotides 5' to
the usual splice acceptor site for exon 2. There are also
potential alternative splicing signals at amino acids 6 and 38
in the H-2Dd gene sequence. It is worth noting that use of the
alternative splicing signals would remove the only protein
sequence that is conserved between all class I and class II
,l-chain sequences-namely, the sequence Val-Arg-Phe-
Asp-Ser-Asp at amino acid positions 34-39 (28). It has been
suggested that this sequence could be involved in inter-
actions with T-cell molecules. The potential consequences of
its removal are, however, unclear.
A second region of the H-2Dd gene, the seventh intron,
also contains potential alternative splice sites. The H-2Dd
cDNA clones pH-2d_1 and pH-21 both contain eight exon
sequences that are only 5 nucleotides long and correspond to
the exon 8 sequence indicated in Fig. 2. There is a potential
alternative splice acceptor sequence located 27 nucleotides
5' to the splice acceptor site used by the H-2Dd cDNAs, as
indicated in Fig. 2. This potential splice acceptor site cor-
responds to the splice acceptor site used by the H-2Kk,
H-2Kb, and H-2Kd messenger RNAs (6, 7, 29, 30).
The presence of potential alternative splice signals in the
H-2Dd gene raises the obvious question of whether they
might be used. They are not used by any H-2Dd cDNAs so
far described. It is interesting to note that all of the potential
alternative splice acceptor sites noted in the H-2Dd gene
share the following structure: A-G-(C/T). All but one of the
splice acceptor sites known to be used by H-2Dd transcripts
have the structure A-G-(A/G). The only exception is the
acceptor site for exon 8, which has the sequence A-G-T.
Perhaps the A-G-(C/T) structure is less efficiently used as a
splice site by the splicing machinery of the cell than the
A-G-(A/G) structure.
From comparisons between the fourth exons of the H-
2Dd, H-2Ld, H-2Kd, and H-2Kb genes, it is apparent that the
frequency of use of a particular splice signal may depend not
only on its sequence but also on its surroundings. Exon 4 of
the H-2Dd gene encodes 95 amino acids, while the fourth
exons of the H-2Ld, H-2Kb, and H-2Kd genes encode only 92
amino acids. This results from the absence of a splice donor
site in the H-2Dd gene at a position corresponding to the
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position of the splice donor sites at the ends of the fourth
exons of these other genes. The H-2Ld, H-2Kd, and H-2Kb
genes all have a potential splice donor site that corresponds
to the site at the end of the fourth exon of the H-2Dd gene,
but apparently these potential alternative splice sites are not
used. It is worth noting that H-2Kd messages use the rather
unusual splice donor site A-G-T, located after the 92nd
codon in exon 4, rather than splicing at the more common
splice donor site G-G-T, which is found nine nucleotides
downstream. Thus, in this case, the position of the splice
site, rather than its sequence, seems to dictate whether it is
used.
There is a third cDNA whose DNA sequence is >99%
homologous to the coding sequence of the H-2Dd gene. This
is pAG64, a cDNA derived from simian virus 40-transformed
fibroblasts (31). According to the report, this cDNA repre-
sents a transcript that is present only in simian virus 40-
transformed cells. Originally, it was not identified as an
H-2Dd transcript because its sequence was not identical to
that of gene Ch4a-Dd (13). Gene Ch4a-Dd, which has been
partially sequenced, was identified as an H-2Dd gene, but it
disagrees with the H-2Dd protein sequence at 11 positions
(see Discussion). The pAG64 sequence differs from the
coding sequence of gene c49.2 in only 1/1412 nucleotides.
Thus, it is almost certainly derived from an H-2Dd gene
transcript. This cDNA is unusual in two respects. It com-
pletely lacks exon 7 sequences, and it fails to terminate at the
polyadenylylation site used by pH-2d-1, continuing instead
for an extra 150 nucleotides. Other cDNAs derived from the
same cDNA library as pAG64, pAG85 and pAG86, are
identical in sequence to pAG64 except for the fact that they
contain exon 7 sequences (31). Thus, it appears that exon 7
can also be involved in alternative splicing of H-2Dd tran-
scripts.
The H-2Dd Gene Is Homologous to the Other H-2d Ha-
plotype Transplantation Antigen Genes. Comparisons be-
tween the sequence of the H-2Dd gene and the sequences of
the other H-2d haplotype genes, the H-2Kd and H-2Ld genes,
reveal several interesting points. First, the introns are at
least as related to each other as are the exons. The introns of
the H-2Dd gene are 87%-97% homologous to the cor-
responding intron of the H-2Ld and H-2Kd genes, whereas
the exons are 85%-100% homologous at the DNA level. This
differs from the situation in other multigene families, such as
the globins, where the introns are much less homologous to
each other than are the exons (32, 33). Perhaps the conserva-
tion of the introns arises from gene conversion events among
these genes, as will be further discussed. The only significant
region of nonhomology between the DNA sequences of the
H-2Dd, H-2Ld, and H-2Kd introns is associated with se-
quences in the third intron that are homologous to the
consensus sequence of the B1 highly repetitive sequence
family of the mouse (34). The areas of nonhomology result
from differences in sequence and in length of the thymine-
rich region, which is located next to the B1 sequences. The
B1 sequences themselves are located in homologous posi-
tions in all three genes, ="600 nucleotides 3' to the end of
exon 3.
From the DNA sequence comparisons, it is also apparent
that, for most of the length of the H-2Dd gene, it is not
significantly more related to the H-2Ld gene than to the
H-2Kd gene, despite the fact that the H-2Dd and H-2Ld genes
are tightly linked and separated from the H-2Kd gene by
-0.3 centimorgans (1-3). The only region of the H-2Dd gene
to display significantly higher homology to the H-2Ld gene
than to the H-2Kd gene is the 3' untranslated region. Up to a
point 309 nucleotides 3' to the termination codon, the 3'
untranslated region of the H-2Dd gene is, if anything, more
homologous to the H-2Kd gene than to the H-2Ld gene (94%
versus 88% homology). After this point, however, the H-2Dd
and H-2Ld genes, which remain homologous to each other
and to the H-2Db cDNA (17), diverge completely from the
sequence of the H-2Kd, H-2Kb, Q10 (35), and 27.1 (25) genes.
Q10 is a nonpolymorphic Qa gene. As was noted in the
discussion of the cDNA clone pAG64 (31), the divergence
between these two groups of sequences results from the
insertion of a sequence that is 84% homologous to the
consensus sequence of the B2 repeated sequence family (36).
This sequence is present in the 3' untranslated region of the
H-2D subregion genes but not in the other class I 3' flanking
sequences. It is flanked by 9-base-pair direct repeats, as
indicated in Fig. 2. As direct repeats are associated with the
insertion of a transposable element, it has been suggested
that this sequence represents the result of a transposition of
a member of the B2 family (31). This possibility is particu-
larly attractive because the homology to the H-2K and Qa
genes resumes after the second direct repeat flanking the B2
sequence.
The H-2Dd Protein Sequence Is Homologous to the Protein
Sequences of Other Class I Molecules. Comparisons between
the translated H-2Dd gene coding sequence and the protein
sequences of other class I molecules are presented in Fig. 3.
Overall, the H-2Dd protein sequence is 85% homologous to
the H-2Ld protein, 84% homologous to the H-2Db protein,
80% homologous to the H-2Kd protein, and 86% homologous
to the H-2Kb protein. In general, the H-2Dd sequence is
more homologous to the transplantation antigen sequences
than it is to the sequences of the Qa region molecules.
It has been suggested that the observed polymorphism of
the transplantation antigens is generated, at least in part, by
multiple small gene conversion events (37). Comparison of
the H-2Dd gene sequence with the sequences of the other
transplantation antigen genes does not reveal any obvious
signs of clearcut gene conversion events. Indeed, if the
pattern of homologies observed in these comparisons was
partially generated by gene conversion, it would be expected
that it required many small gene conversion events that
would have erased traces of previous events. In addition,
even given a region in which two genes share sequence, it is
difficult to determine which gene was the donor and which
was the recipient in a possible gene conversion event.
DISCUSSION
The sequence of the H-2Dd gene in c49.2 is a complete
sequence of an H-2Dd gene and the only genomic sequence
known to be in full agreement with the available H-2Dd
protein sequence data. The partial sequence of the class I
gene in clone Ch4A-Dd, which was identified as an H-2Dd
gene based on the reactivity of its transfected product with
H-2Dd-specific monoclonal antibodies, disagrees with the
H-2Dd protein sequence at 11/142 residues (13). These
sequence differences are puzzling in light of the serological
data, particularly as five of the changes result in charge
changes. These differences could have arisen by somatic
mutation, as clone Ch4A-Dd was derived from a genomic
library made from MOPC41 BALB/c tumor cells. It is also
possible, of course, that the class I gene in clone Ch4a-Dd
represents a second H-2Dd-like gene. If so, it is a very
unusual class I gene, because class I gene introns are as
homologous to each other as class I gene exons, and introns
1 and 2 of gene Ch4a-Dd are almost impossible to align with
introns 1 and 2 of our H-2Dd gene. It is also possible that the
differences in the Ch4A-Dd sequence arose as a result of
sequencing errors.
The H-2Dd protein sequence predicted from the c49.2 gene
sequence is 80Y-85% homologous to the protein sequences
of other transplantation antigens. In particular, it is 84%
homologous to the H-2Db sequence, a level of homology
comparable to that found between the only previously
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sequenced alleles, H-2Kb and H-2Kd (83%). The restriction
maps of the H-2Db and H-2Dd genes and their flanking
sequences are quite similar, as would be expected for allelic
genes (8). Although it has been argued that, based on their
unprecedented level of sequence homology (95%), the H-2Ld
and H-2Db genes are allelic (13, 18), it could equally well be
argued that (i) the H-2Db and H-2Dd genes are alleles,
because they are as homologous to each other as are the
H-2Kb and H-2Kd genes, and (ii) the H-2Ld gene arose from
some unequal crossover event that inserted a copy of an
H-2Db-like gene next to the resident H-2Dd gene. In a
situation such as this, where there is considerable
polymorphism and where there are different numbers of
genes in corresponding genetic subregions, it is difficult to
determine which pairs of genes are allelic.
Three distinct class I genes have been cloned and mapped
to the H-2Dd subregion in BALB/c mice. Several clones
containing the H-2Ld gene have been isolated (refs. 9-11;
unpublished observations). A second H-2D-subregion gene,
located on the cosmid c16.1, has an unknown function. L
cells transfected with this gene do not produce any cell-
surface molecules that react with any of the available anti-
BALB/c H-2D subregion antisera (12). Thus, this class I
gene could be a pseudogene, could encode a cell-surface
protein not detectable in this assay, or could encode a
secreted or cytoplasmic class I-like protein. Several cosmid
clones containing H-2Dd genes have been isolated (refs. 11
and 18; Y. H. Sun, personal communication). Their maps
fall into two categories; c49.2-like and c18.1-like. The re-
striction maps of the two types of clones differ only in the 3'
sequence flanking the H-2Dd gene. After their maps diverge,
there is no DNA homology between the two types of clones.
While several c49.2-like clones have been isolated, c18.1 is
the only representative clone of its type (Y. H. Sun, per-
sonal communication). Based on this fact as well as on
restriction polymorphism mapping and preliminary sequence
analysis, it appears that the differences in the maps are the
result of a cloning artifact affecting c 18.1 (unpublished
observations). Thus, both types of clone probably contain
the same H-2Dd gene.
The presence in the H-2Dd gene of alternative splicing
signals homologous to those used by other class I genes is
intriguing. If used, they could generate H-2Dd1like proteins
that might be useful for novel functions. Use of the potential
alternative signals in and around exon 2 of the H-2Dd gene
would generate cell-surface molecules that share some
antigenic specificities with H-2Dd, lack other H-2Dd speci-
ficities, and have yet others of their own. This could resolve
the discrepancy between the serological evidence for the
existence of other H-2D-encoded molecules in the H-2d
haplotype and the lack of any additional cloned class I genes
mapping to this region.
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